NELL-1 enhanced bone mineralization
View Patent ↗Provided herein are methods for enhancing bone mineralization for bone repair or regeneration and compositions and grafts therefor. Methods for screening agents that enhance or modulate NELL-1 gene expression or NELL-1 protein production in a cell are also provided.
1. A method of increasing bone mineralization, the method comprising increasing the concentration of a NELL-1 gene product in an osteogenic cell by administering a NELL-1 gene product in an effective amount to the osteogenic cell;
wherein the NELL-1 gene product is a NELL-1 protein or an osteogenic fragment thereof,
wherein the NELL-1 protein comprises the amino acid sequence of SEQ ID NO: 1 or 8.
2. The method of claim 1 , wherein the osteogenic cell is selected from the group consisting of a mature osteoblast, an osteoblast, a mesenchymal cell, a fibroblast cell, a fetal embryonic cell, a stem cell, a bone marrow cell, a dura cell, a chrondrocyte, and a chondroblast.
3. A method of facilitating the repair of bone fractures, the method comprising increasing the concentration of a NELL-1 gene product at or near the fracture site by administering a composition comprising a NELL-1 gene product at or near the bone fracture site,
wherein the NELL-1 gene product is a NELL-1 protein or an osteogenic fragment thereof,
wherein the NELL-1 protein comprises the amino acid sequence of SEQ. ID. NO: 1 or 8.
4. A method of facilitating the repair of a bone fracture, the method comprising administering to the bone fracture site a composition comprising a NELL-1 protein,
wherein the NELL-1 protein comprises the amino acid sequence of SEQ ID NO: 1 or 8.
5. The method of claim 4 , wherein the composition further comprises a pharmaceutically acceptable carrier.
6. The method of claim 5 , wherein the pharmaceutically acceptable carrier comprises collagen.
7. A method of treating, preventing or ameliorating osteoporosis by administering to a bone tissue at a pre-selected site an effective amount of a NELL-1 protein or an osteogenic fragment thereof, wherein the NELL-1 protein comprises the sequence of SEQ ID NO: 1 or 8.
8. The method of claim 7 , further comprising applying to the pre-selected site a physical force to disperse the NELL-1 protein.
9. The method of claim 8 , wherein the administering step comprises:
making an incision in the bone tissue at the pre-selected site, and
delivering to the bone tissue at the pre-selected site via the incision.
10. The method of claim 8 , wherein the physical force is ultrasound.
11. The method of claim 7 , wherein the NELL-1 protein is formulated into a formulation suitable for a mode of delivery selected from percutaneous injection through intact skin to a site, direct injection through a surgically opened site or a trauma site, surgical implantation, extravascular delivery, extravascular injection, extravascular catheter based injection, intravascular delivery, intravascular injection, intravascular catheter based injections, intravenous delivery, intravenous injection, intravenous catheter based injections, intraarterial delivery, intraarterial injection, intraarterial catheter based injections, intrathecal delivery, intrathecal injection, intrathecal catheter based injections, intraosseous delivery, intraosseous injection, catheter based injections, intracartilaginous delivery, intracartilaginous injection, intracartilaginous catheter based injections, intravesical delivery, intravesical injection, intravesical catheter based injection, delivery via a mechanical pump with a percutaneous or implantable catheter, catheter based delivery to an area or organ in the body, or delivery via expanded dispersion through a device that increases tissue penetration or wider tissue distribution.
12. The method of claim 11 , wherein the device provides ultrasound, iontophoresis, heat or pressure.